Fluorine in PDB 3f66: Human C-Met Kinase in Complex with Quinoxaline Inhibitor
Enzymatic activity of Human C-Met Kinase in Complex with Quinoxaline Inhibitor
All present enzymatic activity of Human C-Met Kinase in Complex with Quinoxaline Inhibitor:
2.7.10.1;
Protein crystallography data
The structure of Human C-Met Kinase in Complex with Quinoxaline Inhibitor, PDB code: 3f66
was solved by
C.Meier,
T.Ceska,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
20.00 /
1.40
|
Space group
|
P 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
47.377,
47.587,
75.600,
100.70,
103.62,
98.29
|
R / Rfree (%)
|
16.8 /
22.5
|
Other elements in 3f66:
The structure of Human C-Met Kinase in Complex with Quinoxaline Inhibitor also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Human C-Met Kinase in Complex with Quinoxaline Inhibitor
(pdb code 3f66). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Human C-Met Kinase in Complex with Quinoxaline Inhibitor, PDB code: 3f66:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 3f66
Go back to
Fluorine Binding Sites List in 3f66
Fluorine binding site 1 out
of 6 in the Human C-Met Kinase in Complex with Quinoxaline Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human C-Met Kinase in Complex with Quinoxaline Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1
b:29.9
occ:1.00
|
F17
|
A:IHX1
|
0.0
|
29.9
|
1.0
|
C14
|
A:IHX1
|
1.3
|
26.8
|
1.0
|
F15
|
A:IHX1
|
2.1
|
42.3
|
1.0
|
F16
|
A:IHX1
|
2.1
|
28.3
|
1.0
|
C12
|
A:IHX1
|
2.3
|
23.0
|
1.0
|
C11
|
A:IHX1
|
2.8
|
18.9
|
1.0
|
C10
|
A:IHX1
|
3.5
|
21.4
|
1.0
|
CD2
|
A:LEU1140
|
3.6
|
24.2
|
1.0
|
CA
|
A:GBL3
|
3.6
|
22.1
|
1.0
|
O
|
A:GBL3
|
3.6
|
22.1
|
1.0
|
CD1
|
A:LEU1157
|
3.9
|
28.4
|
1.0
|
C
|
A:GBL3
|
3.9
|
20.3
|
1.0
|
C7
|
A:IHX1
|
4.2
|
21.3
|
1.0
|
CB
|
A:LEU1157
|
4.6
|
21.7
|
1.0
|
C9
|
A:IHX1
|
4.6
|
22.7
|
1.0
|
CB
|
A:ALA1226
|
4.8
|
23.0
|
1.0
|
CG
|
A:LEU1140
|
4.8
|
19.3
|
1.0
|
CG
|
A:LEU1157
|
4.8
|
23.6
|
1.0
|
CD1
|
A:LEU1140
|
4.8
|
24.4
|
1.0
|
CG
|
A:MET1211
|
4.9
|
22.2
|
1.0
|
C8
|
A:IHX1
|
4.9
|
19.3
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 3f66
Go back to
Fluorine Binding Sites List in 3f66
Fluorine binding site 2 out
of 6 in the Human C-Met Kinase in Complex with Quinoxaline Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human C-Met Kinase in Complex with Quinoxaline Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1
b:42.3
occ:1.00
|
F15
|
A:IHX1
|
0.0
|
42.3
|
1.0
|
C14
|
A:IHX1
|
1.3
|
26.8
|
1.0
|
F17
|
A:IHX1
|
2.1
|
29.9
|
1.0
|
F16
|
A:IHX1
|
2.2
|
28.3
|
1.0
|
C12
|
A:IHX1
|
2.3
|
23.0
|
1.0
|
C11
|
A:IHX1
|
2.9
|
18.9
|
1.0
|
C10
|
A:IHX1
|
3.2
|
21.4
|
1.0
|
CD1
|
A:LEU1157
|
3.2
|
28.4
|
1.0
|
CB
|
A:ALA1108
|
3.5
|
27.2
|
1.0
|
CB
|
A:LEU1157
|
3.6
|
21.7
|
1.0
|
CG
|
A:LEU1157
|
4.1
|
23.6
|
1.0
|
CG1
|
A:VAL1092
|
4.1
|
25.9
|
1.0
|
C7
|
A:IHX1
|
4.2
|
21.3
|
1.0
|
C9
|
A:IHX1
|
4.4
|
22.7
|
1.0
|
O
|
A:ALA1108
|
4.6
|
29.5
|
1.0
|
CA
|
A:ALA1108
|
4.7
|
26.5
|
1.0
|
C
|
A:ALA1108
|
4.8
|
24.6
|
1.0
|
O
|
A:PRO1158
|
4.8
|
23.3
|
1.0
|
C8
|
A:IHX1
|
4.8
|
19.3
|
1.0
|
CA
|
A:LEU1157
|
4.9
|
21.8
|
1.0
|
CG2
|
A:VAL1092
|
5.0
|
26.3
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 3f66
Go back to
Fluorine Binding Sites List in 3f66
Fluorine binding site 3 out
of 6 in the Human C-Met Kinase in Complex with Quinoxaline Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human C-Met Kinase in Complex with Quinoxaline Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1
b:28.3
occ:1.00
|
F16
|
A:IHX1
|
0.0
|
28.3
|
1.0
|
C14
|
A:IHX1
|
1.3
|
26.8
|
1.0
|
F17
|
A:IHX1
|
2.1
|
29.9
|
1.0
|
F15
|
A:IHX1
|
2.2
|
42.3
|
1.0
|
C12
|
A:IHX1
|
2.4
|
23.0
|
1.0
|
C10
|
A:IHX1
|
2.8
|
21.4
|
1.0
|
O
|
A:PRO1158
|
3.2
|
23.3
|
1.0
|
CB
|
A:LEU1157
|
3.4
|
21.7
|
1.0
|
C11
|
A:IHX1
|
3.6
|
18.9
|
1.0
|
CD2
|
A:LEU1140
|
3.7
|
24.2
|
1.0
|
CD1
|
A:LEU1140
|
3.9
|
24.4
|
1.0
|
CD1
|
A:LEU1157
|
4.0
|
28.4
|
1.0
|
CB
|
A:ALA1108
|
4.0
|
27.2
|
1.0
|
C9
|
A:IHX1
|
4.1
|
22.7
|
1.0
|
CG
|
A:LEU1157
|
4.2
|
23.6
|
1.0
|
CG
|
A:LEU1140
|
4.3
|
19.3
|
1.0
|
C
|
A:PRO1158
|
4.3
|
20.9
|
1.0
|
C
|
A:LEU1157
|
4.4
|
22.8
|
1.0
|
N
|
A:PRO1158
|
4.4
|
22.7
|
1.0
|
CA
|
A:LEU1157
|
4.5
|
21.8
|
1.0
|
CG
|
A:MET1160
|
4.5
|
19.6
|
1.0
|
CD
|
A:PRO1158
|
4.6
|
24.1
|
1.0
|
C7
|
A:IHX1
|
4.8
|
21.3
|
1.0
|
CD2
|
A:LEU1157
|
4.8
|
23.9
|
1.0
|
O
|
A:LEU1157
|
4.9
|
23.8
|
1.0
|
N21
|
A:IHX1
|
4.9
|
23.6
|
1.0
|
C8
|
A:IHX1
|
5.0
|
19.3
|
1.0
|
CA
|
A:PRO1158
|
5.0
|
23.0
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 3f66
Go back to
Fluorine Binding Sites List in 3f66
Fluorine binding site 4 out
of 6 in the Human C-Met Kinase in Complex with Quinoxaline Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human C-Met Kinase in Complex with Quinoxaline Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F2
b:35.4
occ:1.00
|
F17
|
B:IHX2
|
0.0
|
35.4
|
1.0
|
C14
|
B:IHX2
|
1.3
|
27.4
|
1.0
|
F16
|
B:IHX2
|
2.1
|
31.9
|
1.0
|
F15
|
B:IHX2
|
2.2
|
41.1
|
1.0
|
C12
|
B:IHX2
|
2.3
|
23.8
|
1.0
|
C11
|
B:IHX2
|
2.8
|
25.3
|
1.0
|
C10
|
B:IHX2
|
3.5
|
21.6
|
1.0
|
OD
|
B:GBL1
|
3.5
|
29.3
|
1.0
|
O
|
B:GBL1
|
3.7
|
21.6
|
1.0
|
CD1
|
B:LEU1157
|
3.7
|
28.3
|
1.0
|
CD2
|
B:LEU1140
|
3.8
|
26.4
|
1.0
|
C
|
B:GBL1
|
3.9
|
21.4
|
1.0
|
C7
|
B:IHX2
|
4.1
|
21.7
|
1.0
|
CB
|
B:LEU1157
|
4.5
|
23.1
|
1.0
|
C9
|
B:IHX2
|
4.6
|
18.8
|
1.0
|
CG
|
B:LEU1157
|
4.7
|
24.4
|
1.0
|
C8
|
B:IHX2
|
4.8
|
19.1
|
1.0
|
CG
|
B:GBL1
|
4.8
|
19.8
|
1.0
|
CB
|
B:ALA1226
|
4.9
|
25.2
|
1.0
|
CE
|
B:MET1211
|
5.0
|
23.6
|
1.0
|
C4
|
B:IHX2
|
5.0
|
23.8
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 3f66
Go back to
Fluorine Binding Sites List in 3f66
Fluorine binding site 5 out
of 6 in the Human C-Met Kinase in Complex with Quinoxaline Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Human C-Met Kinase in Complex with Quinoxaline Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F2
b:41.1
occ:1.00
|
F15
|
B:IHX2
|
0.0
|
41.1
|
1.0
|
C14
|
B:IHX2
|
1.4
|
27.4
|
1.0
|
F17
|
B:IHX2
|
2.2
|
35.4
|
1.0
|
F16
|
B:IHX2
|
2.2
|
31.9
|
1.0
|
C12
|
B:IHX2
|
2.3
|
23.8
|
1.0
|
C11
|
B:IHX2
|
3.0
|
25.3
|
1.0
|
CD1
|
B:LEU1157
|
3.1
|
28.3
|
1.0
|
C10
|
B:IHX2
|
3.2
|
21.6
|
1.0
|
CB
|
B:ALA1108
|
3.5
|
26.8
|
1.0
|
CB
|
B:LEU1157
|
3.6
|
23.1
|
1.0
|
CG1
|
B:VAL1092
|
3.8
|
27.7
|
1.0
|
CG
|
B:LEU1157
|
4.0
|
24.4
|
1.0
|
C7
|
B:IHX2
|
4.3
|
21.7
|
1.0
|
C9
|
B:IHX2
|
4.4
|
18.8
|
1.0
|
C
|
B:ALA1108
|
4.7
|
25.2
|
1.0
|
CA
|
B:ALA1108
|
4.7
|
23.0
|
1.0
|
O
|
B:ALA1108
|
4.7
|
25.4
|
1.0
|
O
|
B:PRO1158
|
4.8
|
22.5
|
1.0
|
CG2
|
B:VAL1092
|
4.8
|
29.2
|
1.0
|
C8
|
B:IHX2
|
4.8
|
19.1
|
1.0
|
CB
|
B:VAL1092
|
4.9
|
26.9
|
1.0
|
CA
|
B:LEU1157
|
4.9
|
23.2
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 3f66
Go back to
Fluorine Binding Sites List in 3f66
Fluorine binding site 6 out
of 6 in the Human C-Met Kinase in Complex with Quinoxaline Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Human C-Met Kinase in Complex with Quinoxaline Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F2
b:31.9
occ:1.00
|
F16
|
B:IHX2
|
0.0
|
31.9
|
1.0
|
C14
|
B:IHX2
|
1.3
|
27.4
|
1.0
|
F17
|
B:IHX2
|
2.1
|
35.4
|
1.0
|
F15
|
B:IHX2
|
2.2
|
41.1
|
1.0
|
C12
|
B:IHX2
|
2.3
|
23.8
|
1.0
|
C10
|
B:IHX2
|
2.7
|
21.6
|
1.0
|
O
|
B:PRO1158
|
3.1
|
22.5
|
1.0
|
CB
|
B:LEU1157
|
3.3
|
23.1
|
1.0
|
C11
|
B:IHX2
|
3.6
|
25.3
|
1.0
|
CD2
|
B:LEU1140
|
3.8
|
26.4
|
1.0
|
CD1
|
B:LEU1157
|
3.8
|
28.3
|
1.0
|
C9
|
B:IHX2
|
4.1
|
18.8
|
1.0
|
CB
|
B:ALA1108
|
4.1
|
26.8
|
1.0
|
CG
|
B:LEU1157
|
4.1
|
24.4
|
1.0
|
C
|
B:PRO1158
|
4.3
|
19.0
|
1.0
|
N
|
B:PRO1158
|
4.4
|
23.9
|
1.0
|
CD1
|
B:LEU1140
|
4.4
|
24.8
|
1.0
|
C
|
B:LEU1157
|
4.4
|
22.7
|
1.0
|
CA
|
B:LEU1157
|
4.5
|
23.2
|
1.0
|
CD
|
B:PRO1158
|
4.5
|
22.7
|
1.0
|
CG
|
B:LEU1140
|
4.6
|
24.0
|
1.0
|
C7
|
B:IHX2
|
4.7
|
21.7
|
1.0
|
CD2
|
B:LEU1157
|
4.8
|
23.0
|
1.0
|
CG
|
B:MET1160
|
4.8
|
23.4
|
1.0
|
O
|
B:LEU1157
|
4.8
|
21.6
|
1.0
|
C8
|
B:IHX2
|
4.9
|
19.1
|
1.0
|
N21
|
B:IHX2
|
4.9
|
20.4
|
1.0
|
CA
|
B:PRO1158
|
5.0
|
22.1
|
1.0
|
|
Reference:
J.Porter,
S.Lumb,
F.Lecomte,
J.Reuberson,
A.Foley,
M.Calmiano,
K.Le Riche,
H.Edwards,
J.Delgado,
R.J.Franklin,
J.M.Gascon-Simorte,
A.Maloney,
C.Meier,
M.Batchelor.
Discovery of A Novel Series of Quinoxalines As Inhibitors of C-Met Kinase. Bioorg.Med.Chem.Lett. V. 19 397 2009.
ISSN: ISSN 0960-894X
PubMed: 19059779
DOI: 10.1016/J.BMCL.2008.11.062
Page generated: Wed Jul 31 18:24:34 2024
|